MS023 DiHCl (MS-023), the dihydrochloride salt of MS-023, is a PRMTs (Protein arginine methyltransferases) inhibitor with potential anticancer activity.

EZM2302 (EZM-2302; GSK-3359088; GSK3359088) is a potent, selective, and orally bioavailable arginine methyltransferase CARM1 inhibitor with potential anticancer activity.

EPZ004777 hydrochloride, the hydrochloride salt of EPZ-004777, is a novel and potent DOT1L inhibitor with an IC50 value of 400 pM.

Amodiaquin dihydrochloride (trade names Camoquin, Flavoquine) is a potent and orally bioactive inhibitor of the Ebola virus, acts by targeting the viral protein 35 (VP35).

EPZ005687 (EPZ-005687) is a novel, potent and selective inhibitor of EZH2 (a histone lysine N-methyltransferase) with anticancer activity.

SGC2085 HCl, identified from virtual screening approaches, is a potent and selective inhibitor of coactivator associated arginine methyltransferase 1 (CARM1) with an IC50 of 50 nM.

BCI-121 is an SMYD3 inhibitor.

MS1943 (MS-1943) is a novel and potent EZH2 degrader (IC50 = 120 nM) with anticancer activity.

UNC1999 (UNC-1999) is an orally bioavailable, cell-permeable, selective, SAM-competitive and dual inhibitor of EZH2/EZH1 (Enhancer of zeste homolog) with antineoplastic activity.

MM-401 is a novel, potent and selective inhibitor of histone H3K4 methyltransferase MLL1 activity.